FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to gynaecology, and can be used in treating such diseases as dysfunctional uterine bleeding, menorrhagia, dysmenorrhoea, endometriosis, uterine fibroid, menopausal disorders, osteoporosis and urogenital atrophy. That is ensured by presenting an urogenital system comprising a frame forming an internal cavity enclosing an insert with a therapeutically effective dose of a biologically active compound. The insert is form-stable and damage-resistant when in use. The frame has an open structure providing access to a main portion of an external portion of the insert. The frame comprises one or more retaining element for frame holding in the uterine. What is also presented is a method for making the above intrauterine system.
EFFECT: group of inventions provides an effective controlled release drug delivery for a long period of time, as well as easy and safe administration and proper removal of the preparation.
14 cl, 9 dwg
Title | Year | Author | Number |
---|---|---|---|
DEVICE FOR INTRODUCTION | 2009 |
|
RU2494706C2 |
DEVICE FOR INTRODUCTION | 2009 |
|
RU2497486C2 |
COMPLEX FOR INTRAUTERINE SYSTEM AND ITS INSTALLATION TOOL | 2017 |
|
RU2755384C2 |
ULTRASOUND DETECTED INTRAUTERINE SYSTEM AND METHOD FOR ULTRASONIC DETECTION ENHANCEMENT | 2006 |
|
RU2389451C2 |
PLATFORM FOR SILVER ION DELIVERY | 2009 |
|
RU2532389C2 |
POLYMER FRAME FOR INTRAUTERINE DEVICE | 2009 |
|
RU2525272C2 |
DRUG DELIVERY SYSTEM | 2002 |
|
RU2302883C2 |
IMPROVEMENT IN FRAMELESS INTRAUTERINE DEVICES AND SYSTEMS | 2010 |
|
RU2555389C2 |
INTRAUTERINE CONTRACEPTIVE DEVICE | 2007 |
|
RU2440069C2 |
INTRAUTERINE CARRIER | 2008 |
|
RU2503431C2 |
Authors
Dates
2014-09-27—Published
2010-05-03—Filed